Magnetic Resonance Imaging (MRI) Hysterosalpingography Versus Radiographic Hysterosalpingography in Female Infertility
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · Apr 8, 2014
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
Infertility is a disease which affects around 15% of couples (one union of seven) and has been increasing for 10 years. Therefore, and due to the development of methods of medically assisted procreation, demand for infertility evaluation is steadily increasing.
The infertility evaluation always begins with an accurate history, coupled with a physical examination of both partners. Indeed, infertility of a couple is due to the female partner in about two thirds of cases, the male partner in the remaining third of cases. In women, the main observed causes are ovulatory function disorders (10 ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patient who a pelvic MRI and an Hysterography, part of an infertility assessment, have been prescribed by a gynecologist physician in Nice University Hospital.
- • Informed consent signed Patient with social insurance Age \> 18
- Exclusion Criteria:
- • Contraindication to magnetic resonance imaging hysterosalpingography Contraindication to radiographic hysterosalpingography
About Centre Hospitalier Universitaire De Nice
The Centre Hospitalier Universitaire (CHU) de Nice is a leading academic medical center located in Nice, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Nice is committed to enhancing patient care by conducting rigorous studies that explore new therapies and treatment modalities across various medical disciplines. With a focus on collaboration, the center integrates cutting-edge technology and interdisciplinary expertise to ensure the highest standards of research integrity and patient safety. CHU de Nice plays a vital role in the development of evidence-based medicine, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nice, , France
Patients applied
Trial Officials
Madleen CHASSANG, MD
Principal Investigator
Centre Hospitalier Universitaire de Nice
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials